Take part in our research study and be among the first with the chance to access an investigational treatment for excessive sleepiness due to shift work disorder (SWD), while helping to advance important medical research.
Eligible participants will receive up to $1,725 in compensation for completing 14 study visits over approximately 19 weeks.
This research study is designed for adults ages 18 to 65 who have been experiencing symptoms of shift work disorder (SWD), a condition that causes excessive sleepiness and difficulty staying alert during overnight or rotating work shifts. The study is evaluating an investigational medication called solriamfetol to find out if it can help reduce excessive sleepiness related to SWD. Additional objectives are to assess the safety of solriamfetol and how it is processed in the body compared to placebo.
The study is randomized, double-blind, and placebo-controlled to ensure accurate and unbiased results. If you are eligible and choose to participate, there is a 50% chance you will receive solriamfetol and a 50% chance you will receive a placebo. A placebo is an inactive material that looks like solriamfetol but does not contain any active ingredient.
The study consists of a screening period, a treatment period, and a follow-up period, lasting approximately 19 weeks and including up to 6 in person visits and up to 8 remote visits. If you are eligible and participate, you could earn up to $1,725 for your study-related time. Throughout the study, your health and progress will be closely monitored by the study team. By participating, you could help advance research and open the door to potential new treatment options for people living with Shift Work Disorder.
Those who qualify and choose to participate could receive:
Access to the investigational medication at no cost
Access to our top-tier team of board-certified physicians at no cost
Compensation up to $1,725 for 14 visits over approximately 19 weeks
A research study or clinical trial is the process a potential new drug, device, procedure, or process goes through to prove that it is safe, tolerable and effective for the condition it is being studied for. Research studies are the only way to advance medicine for future generations.
Each study has its own set of inclusion and exclusion criteria that a participant must meet before they are allowed to participate in a study. Patients from all backgrounds and walks of life are encouraged to participate.
Every participant in every research study must go through the informed consent process. During this, the trial doctor and research team go over what will happen in the study, what treatments you might get, how long the trial is expected to last, what happens during visits, the potential risks and benefits, and many other important facts about the study. Participants may withdraw their consent and discontinue the study at any time for any reason.
A placebo looks like a treatment but does not have any active medicine in it. Researchers use placebos to help make sure any changes in the participants’ health are actually caused by the study treatment. You do not get to choose if you get the study treatment or the placebo, and you may not know if you get the placebo until after the study. Not all research studies use a placebo.
If studies do not include diverse participants, we cannot know if treatments work for everyone who needs them. Studies only tell researchers how something works for the participants of that study, and they may not work the same in people of different races, ethnicities, ages, or sexes.
All research studies must follow federal laws and ethical guidelines, including HIPAA. Studies must also be approved by an expert group called an institutional review board (IRB) that helps make sure the trial is fair and as safe as possible, and that any risks to the participants are worth the potential benefits.